Systematic reviews: what can they do for you?
Usually, more than one study will have addressed the same question or closely related questions. The most reliable guide to clinical practice is therefore likely to come from a comprehensive and objective review of all available trials, rather than from any single study". However, it is far from easy to identify all trials related to a specific question. For example, trials that report a 'positive' effect are more likely to be identified for inclusion in review, because they are more likely to be: (i) accepted for presentation at meetings 4 ; (ii) reported in print': (iii) published as a full reportv, (iv) published in widely read journals 7 ,8; and (v) cited subsequently in other articles".
Having identified as high a proportion as possible of the relevant trials, it is now common practice (when possible and appropriate) to synthesize data from the individual studies to yield a statistic that summarizes the overall treatment effect. It is this component of a systematic review that is commonly referred to as 'meta-analysis'. Advantages of pooling data from more than one study are that random errors are reduced even further, and that the results may be applicable to a wider range of clinical situations (in other words, generalizability is increased). However, if some relevant studies are not included in the review, this may introduce bias. As in primary research, when conducting a review (secondary research) one must strive to minimize not only random error but also systematic errors.
The process of minimizing bias in reviews should begin (just as it docs in primary research) with the development of a protocol! o. The methods outlined at the protocol stage can then very easily be incorporated into a structured report of the completed review. Those who read the report need to be able to decide for themselves whether adequate measures were taken to control biases in the review, and if not, how the biases might have influenced the overall conclusions 1J, 12. This is only possible if the published review includes a 'Materials and Methods' section. Until very recently, few reviews had any such section! l.
A common and widely used type of review is the medical textbook. Even fewer of these than journal article reviews include a description of the 'Materials and Methods' used to generate their contents. Their role was recently defended as ,
. li " " h lk I h provJ( mg . . . a way in on t e bu of diseases t at [students and doctors] are likely to encounter"!". Unfortunately this defence failed to address the fundamental issue-
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Until the second half of this century, medical science advanced slowly and the training received at the start of a doctor's career was, in many respects, likely to reflect acceptable practice until retirement. The increasing rate of medical progress has changed all that. Today, if clinicians want to be reasonably sure that they are offering forms of care that will be beneficial, and withdrawing forms of care likely to be useless or harmful, they must be up with the latest evidence. This is a daunting task. With over 2 million biomedical articles published every year nobody can read all the primary research, even within a very specialized area.
Increasingly, therefore, not only clinicians but also policy makers, purchasers of care, and those who use the health services are relying on reviews of research findings. Traditionally, reviews have been relatively subjective and have not followed scientific principles. Thus different reviewers have sometimes reached conflicting conclusions from the same body of evidence, adding to confusion about what clinicians ought to do. Here I seck to show that high quality systematic reviews 1 are a better way to help busy clinicans tackle some of the uncertainties of everyday practice. The focus will be on assessing effects of health care interventions, although similar methods can be applied to other types of work such as evaluation of diagnostic and screening tests/ or assessment of prognosis.
A fundamental principle of health care is that any intervention should, overall, do more good than harm. There is a problem, however: unless the real effects of any intervention (whether beneficial or harmful) are very large they are likely to be confused with the effects of both systematic errors (bias) and random errors (the play of chance). For most interventions the best that can be hoped for are small or moderate benefits-for example, a 10%--20% reduction in mortality or in some important measure of morbiditiv. So, if we are to avoid being misled, steps must be taken to minimize both bias and random errors. The most reliable evidence about these moderate effects of care comes from randomized trials, where randomization ensures that at the point when people are being allocated to a particular intervention there are no systematic differences between the groups. If the trial is also large, random errors will be small. routine care following myocardial infarction. This appeared to be contradicted by data from the huge ISIS-4 trial 27, which did not demonstrate clear benefit despite randomization of nearly 60000 people. Although one interpretation (eagerly embraced by some) is that this example illustrates the inherent dangers of all statistical synthesis, there are more plausible possible explanations-f. The most plausible relates to how the studies were identified for inclusion in this meta-analysis (that is, publication bias), with small positive trials being more likely to be published than negative ones, and the larger trials tending to report smaller effects. This has been elegantly demonstrated by Egger and Davey Smith who used a funnel plot to show graphically that the small trials included in this meta-analysis were all positive studies-strongly suggesting that small negative trials were not identified for inclusion in the meta-analysis (Figure 1) 28.
Another concern expressed about meta-analysis is that it is 'potentially a dangerous tool in wrong hands'?", The same could be said of most things, from kitchen knives through to randomized trials. Potential dangers in meta-analyses can be limited by ensuring that there has been a proper search strategy to identify studies eligible to be included, that potentially eligible studies have been appropriately assessed for methodological quality, and that these methods are all adequately described in the report. This strategy provides double protection, in that bias in the data selected for statistical synthesis will be minimized, but also readers will be able to decide for themselves whether the results are 243 a 1515-4 Magnesium 10 Patients 10 5 namely, that authors of textbook chapters should make explicit how they arrived at their conclusions. In other words, textbooks, just like other reviews, should describe the materials and methods used. If these were not standardized, then each chapter should present relevant methods. That this approach is possible is demonstrated by at least two widely used books 15,16. We now know that conventional methods for identifying randomized, or possibly randomized, trials are inadequate. For example, MEDLINE is probably the most widely used bibliographic database in the health sciences; yet, until lately, even the most comprehensive search would fail to identify half the indexed trials 17 and an average search by a regular MEDLINE user would yield about one-fifth I8. The evaluation of search strategies has so far focused on the use of methodological terms to index study design; the medical subject terms have received rather less attention, and little is known about their specificity and sensitivity19. Another potential difficulty is that the software used to access the database may be faulty20. For other databases, which are so far less well studied, the obstacles are likely to be similar, if not worse. A further difficulty is that the reports of many trials have never been included in MEDLINE anyway. For example, reports of trials in letters, congress abstracts, or books arc unlikely to be indexed, and coverage of the non-English-language work in MEDLINE is poor. In view of the current limitations of bibliographic databases the only way to be sure that all trials, wherever published and in whatever language, are identified and tagged is to search relevant journals manually!", These measures, no matter how well they are implemented, will only identify studies in the public domain. For various reasons, some trials remain unpublished 21 ,22. An estimated 25%-50% of trials arc completed but never published'' and, since these trials are more likely to have 'negative' results than those which do eventually appear in print'', any review is liable to bias. Of the strategies that have been tried for identification of unpublished trials, none has been notably cffectivc/". The best long-term solution is a system of prospective registration5,24. possible mechanisms for such a register include registration at the time of funding and of approval by an ethics committee 24,25.
Meta-analysis (the statistical synthesis of data from different studies), although only one (and a non-essential) component of a systematic review, has received far more attention than the more mundane topic of how to identify all the relevant trials. Failure to acknowledge the importance of a thorough search strategy for relevant trials has fuelled recent controversy about the value of meta-analysis. The conclusion from a meta-analysis published in 1993 26 was that intravenous magnesium was an 'effective, safe, simple, and inexpensive' intervention that should be introduced into likely to be true and, if they are, whether they are relevant to their own circumstances.
Like all medical research, systematic reviews should be viewed with scepticism. There are no simple solutions 30. The synthesis of primary research in systematic reviews is still a young science, and more research is certainly needed to improve and refine the methods. While remaining aware of the limitations of the current techniques, however, we should not forget the alternative-reviews where no attempts have been made to limit bias and the play of chance.
